Our August, 2019 Quick Question, suggested by frequent contributor, Dave McGlasson, demonstrated the variability in clinical antithrombotic therapy bridging policies when a patient requires a procedure. Here is the question and answers provided by 70 participants:
Posts
Aug 31, 2019 9:48am
0 Comments
Aug 30, 2019 4:54pm
According to an August 28, 2019 Medscape post, according to pooled PARTNER 2 results, early anticoagulation was independently associated with fewer strokes after surgical valve replacement (hazard ratio, 0.17; P = .006) but with more minor bleeding after transcatheter valve replacement (HR, 1.72; P = .01).
0 Comments
Aug 30, 2019 4:48pm
From Lori Leppert: I saw a previous post from April 9, 2014 regarding the use of the PTT
1 Comment
Aug 28, 2019 8:42am
I'm curious about how many of our participants monitor vorapaxar (Zontivity®, New American Therapeutics, Inc) antiplatelet therapy.
0 Comments
